Rituximab and immune modulation post unrelated donor transplant as treatment for refractory Burkitt's-like lymphoma.

被引：0
|
作者：
McGuirk, JP
Dix, SP
Belt, RJ
机构：
[1] Oncol & Hematol Associates, Kansas City, MO USA
[2] St Lukes Hosp, Kansas City, MO USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4775
引用
收藏
页码：242B / 242B
页数：1
相关论文
共 14 条
  • [1] Rituximab and hyper-CVAD for adult Burkitt's (BL) or Burkitt's-like (BLL) leukemia or lymphoma.
    Thomas, DA
    Cortes, J
    Giles, FJ
    Faderl, S
    O'Brien, S
    Garcia-Manero, G
    Pierce, S
    Keating, M
    Cabanillas, F
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 804A - 804A
  • [2] Rituximab and hyper-CVAD for adult Burkitt's (BL) or Burkitt's-like (BLL) leukemia or lymphoma.
    Thomas, DA
    Cortes, J
    Giles, FJ
    Faderl, S
    O'Brien, S
    Garcia-Manero, G
    Verstovsek, S
    Pierce, S
    Keating, M
    Cabanillas, F
    Kantarjian, H
    BLOOD, 2002, 100 (11) : 763A - 764A
  • [3] Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab
    Wong, R
    de Lima, M
    Couriel, D
    Giralt, S
    Hosing, C
    Shahjahan, M
    Cheng, YC
    Bruton, J
    Champlin, R
    Khouri, I
    LEUKEMIA & LYMPHOMA, 2003, 44 (05) : 829 - 832
  • [4] Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab
    S Hongeng
    P Tardtong
    S Worapongpaiboon
    A Ungkanont
    S Jootar
    Bone Marrow Transplantation, 2002, 29 : 871 - 872
  • [5] Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab
    Hongeng, S
    Tardtong, P
    Worapongpaiboon, S
    Ungkanont, A
    Jootar, S
    BONE MARROW TRANSPLANTATION, 2002, 29 (10) : 871 - 872
  • [6] Response to re-treatment with rituximab plus salvage-chemotherapy in refractory or relapsed aggressive Non-Hodgkin's lymphoma.
    Borgerding, Andrea
    Hasenkamp, Justin
    Chapuy, Bjoern
    Truemper, Lorenz
    Wulf, Gerald
    Glass, Bertram
    BLOOD, 2006, 108 (11) : 262B - 263B
  • [7] Successful treatment of a patient with post-renal transplant Burkitt's lymphoma using the Hyper-CVAD regimen
    Hummel, H. D.
    Duell, J.
    Middeke, M.
    Einsele, H.
    Wolff, A.
    Topp, M. S.
    ONKOLOGIE, 2011, 34 : 74 - 74
  • [8] Post-transplant Burkitt's leukemia or lymphoma.: Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial)
    Xicoy, B
    Ribera, JM
    Esteve, J
    Brunet, S
    Sanz, MA
    Fernández-Abellán, P
    Feliu, E
    LEUKEMIA & LYMPHOMA, 2003, 44 (09) : 1541 - 1543
  • [9] A retrospective study of the treatment of Burkitt's-like lymphoma in HIV-positive patients with stage III and IV disease: The Saint Vincents Hospital experience.
    Salerno, VE
    Cook, W
    BLOOD, 1997, 90 (10) : 1523 - 1523
  • [10] Clinical outcomes of patients treated with rituximab for relapsed or refractory aggressive non-Hodgkin's lymphoma in the post-transplant setting.
    Pan, D
    Moskowitz, CH
    Zelenetz, AD
    Teruya-Feldstein, J
    Portlock, CS
    BLOOD, 2000, 96 (11) : 405A - 405A
12